2009
DOI: 10.1073/pnas.0906678106
|View full text |Cite
|
Sign up to set email alerts
|

Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma

Abstract: Elevated intraocular pressure (IOP) in glaucoma causes loss of retinal ganglion cells (RGCs) and damage to the optic nerve. Although IOP is controlled pharmacologically, no treatment is available to restore retinal and optic nerve function. We evaluated the effects of NGF eye drops in a rat model of glaucoma. We also treated 3 patients with progressive visual field defects despite IOP control. Glaucoma was induced in rats through injection of hypertonic saline into the episcleral vein. Initially, 2 doses of NG… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
161
0
3

Year Published

2010
2010
2022
2022

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 200 publications
(168 citation statements)
references
References 40 publications
3
161
0
3
Order By: Relevance
“…5 In the retina, nerve growth factor is produced and used by retinal ganglion cells (RGCs) and bipolar neurons, as well as glial cells, in a local paracrine/autocrine fashion. Previous studies [5][6][7] showed that nerve growth factor can protect retinal ganglion cells. Lambiase and colleagues 7 reported that patients with advanced glaucoma treated with nerve growth factor eyedrops (200 mg/ml) four times daily for three months demonstrated long lasting improvements in visual field, optic nerve function, contrast sensitivity and visual acuity.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…5 In the retina, nerve growth factor is produced and used by retinal ganglion cells (RGCs) and bipolar neurons, as well as glial cells, in a local paracrine/autocrine fashion. Previous studies [5][6][7] showed that nerve growth factor can protect retinal ganglion cells. Lambiase and colleagues 7 reported that patients with advanced glaucoma treated with nerve growth factor eyedrops (200 mg/ml) four times daily for three months demonstrated long lasting improvements in visual field, optic nerve function, contrast sensitivity and visual acuity.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies [5][6][7] showed that nerve growth factor can protect retinal ganglion cells. Lambiase and colleagues 7 reported that patients with advanced glaucoma treated with nerve growth factor eyedrops (200 mg/ml) four times daily for three months demonstrated long lasting improvements in visual field, optic nerve function, contrast sensitivity and visual acuity. Meanwhile, nerve growth factor exerted neuroprotective effects, inhibiting apoptosis of retinal ganglion cells in animals with glaucoma.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Yang et al reported that NGF applied after MCAO reduced apoptosis, and NGF's neuroprotective effect lasted up to five hours [74]. NGF eye drops applied to a rat model of experimental glaucoma improved the long-term function of the optic nerve, widened the visual field, and inhibited apoptosis in retinal ganglion cells [75].…”
Section: Ngf and Apoptosismentioning
confidence: 99%
“…Подальші дослідження показали, що ФРНТ не є гормоном, який викликає тимчасову метаболічну реакцію. Він виявився раніше невідомим видом молекулярної речовини, необхідної для розвитку та виживання ви-сокодиференційованих клітин [28][29][30][31]. У наступні роки було винайдено і інші фактори росту, у тому числі епідермальний фактор росту, фактори-стимулятори колоній, фактор росту тромбоцитарного походження, фактор росту фібробластів та інтерлікіни (1 та 2) [32][33][34][35][36][37][38][39].…”
unclassified